Abstract
Female pattern hair loss typically presents with a history of gradual thinning of scalp hair and widening of the central parting. The prevalence and severity increase with age. Hair loss is due to a gradual decline in the production of hair by scalp hair follicles culminating in follicular miniaturization. Medical treatment can help to prevent progression of hair loss and may promote modest regrowth of hair but is probably unable to reverse follicular miniaturization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baldwin LG, Gafford JA (1936) Arrhenoblastoma case report. Endocrinology 20:373–382
Birch MP, Messenger JF, Messenger AG (2001) Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 144:297–304
Carmina E, Lobo RA (2003) Treatment of hyperandrogenetic alopecia in women. Fertil Steril 79(1):91–95
Cash TF, Price VH, Savin RC (1993) Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 29(4):568–575
Cela E, Robertson C, Rush K et al (2003) Prevalence of polycystic ovaries in women with androgenetic alopecia. Eur J Endocrinol 149(5):439–442
Courtois, MG, Loussouarn G, Hourseau C et al (1995) Ageing and hair cycles. Br J Dermatol 132(1):86–93
Ellis JA, Stebbing M, Harrap SB (2001) Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116(3):452–455
Futterweit W, Dunaif A, Yeh HC, Kingsley P (1988) The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol 19(5 Pt 1):831–836
Guarrera M, Rebora A (2005) Kenogen in female androgenetic alopecia. A longitudinal study. Dermatology 210(1):18–20
Hamilton JB (1942) Male hormone stimulation is pre-requisite and an incitant in common baldness. Am J Anat 71: 451–480
Hayes VM, Severi G, Eggleton SA et al (2005) The E211 G > A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 14(4):993–996
Hillmer AM, Hanneken S, Ritzmann S et al (2005) Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 77(1):140–148
Hillmer AM, Brockschmidt FF, Hanneken S et al (2008) Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 40(11):1279–1281
Iorizzo M, Vincenzi C, Voudouris S et al (2006) Finasteride treatment of female pattern hair loss. Arch Dermatol 142(3):298–302
Jacobs JP, Szpunar CA, Warner ML (1993) Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol 32(10):758–762
Jaworsky C, Kligman AM, Murphy GF (1992) Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol 127(3):239–246
Kantner AE, Ragins AB (1941) Arrhenoblastoma of the ovary. Am J Obstet Gynecol 42:1061–1066
Kuster W, Happle R (1984) The inheritance of common baldness: Two B or not two B? J Am Acad Dermatol 11:921–926
Lucky AW, Piacquadio DJ, Ditre CM et al (2004) A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 50(4):541–553
Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97(3):247–254
Messenger AG, Sinclair R (2006) Follicular miniaturization in female pattern hair loss: clinicopathological correlations. Br J Dermatol 155(5):926–930
Norwood OT (2001) Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 27(1):53–54
O’Driscoll JB, Mamtora H, Higginson J et al (1994) A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenetic alopecia. Clin Endocrinol 41(2):231–236
Olsen EA (1991). Topical minoxidil in the treatment of androgenetic alopecia in women. Cutis 48(3):243–248
Olsen EA (2001) Female pattern hair loss. J Am Acad Dermatol 45(Suppl):S70–80
Orentreich N (1960) Pathogenesis of alopecia. J Soc Cosmet Chemists 11:479–499
Osborn D (1916) Inheritance of baldness. J Hered 7(42):347–355
Paik JH, Yoon JB, Sim WY, Kim BS et al (2001) The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 145(1):95–99
Peluso AM, Misciali C, Vincenzi C, Tosti A (1997) Diffuse hypertrichosis during treatment with 5% topical minoxidil. Br J Dermatol 136(1):118–120
Price VH, Menefee E (1990) Quantitative estimation of hair growth. I. androgenetic alopecia in women: effect of minoxidil. J Invest Dermatol 95(6):683–687
Price VH, Roberts JL, Hordinsky M et al (2000) Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 43(5):768–767
Rebora, A, Guarrera M (2002) Kenogen. A new phase of the hair cycle? Dermatology 205(2):108–110
Rushton DH, Futterweit W, Kingsley D et al (1991) Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia. J Soc Cosmet Chem 42:317–325
Schmidt JB, Lindmaier A, Trenz A et al (1991) Hormone studies in females with androgenic hair loss. Gynecol Obstet Invest 31:235–239
Shum KW, Cullen DR, Messenger AG (2002) Hair loss in women with hyperandrogenism: four cases responding to finasteride. J Am Acad Dermatol 47(5):733–739
Sinclair R, Jolley D, Mallari R, Magee J (2004) The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. J Am Acad Dermatol 51(2):189–199
Sinclair R, Wewerinke M, Jolley D (2005) Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol 152(3):466–473
Smith MA, Wells RS (1964) Male-type alopecia, alopecia areata and normal hair in women. Arch Dermatol 89:155–158
Unger WP, Unger RH (2003) Hair transplanting: an important but often forgotten treatment for female pattern hair loss. J Am Acad Dermatol 49:853–860
Vexiau P, Chaspoux C, Boudou P et al (2002) Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 146(6):992–999
Whiting DA (1993) Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol 28:755–763
Whiting DA (1996) Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35(6):899–906
Whiting DA, Jacobson C (1992) Treatment of female androgenetic alopecia with minoxidil 2%. Int J Dermatol 31(11):800–804
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mohungoo, M.J., Messenger, A.G. (2010). Female Pattern Hair Loss. In: Trüeb, R., Tobin, D. (eds) Aging Hair. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02636-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-02636-2_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02635-5
Online ISBN: 978-3-642-02636-2
eBook Packages: MedicineMedicine (R0)